The Saratov State Medical University is a public university located in Saratov, Saratov Oblast, Russia.

During the past decade, Saratov State Medical University conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 24 clinical trials were completed, i.e. on average, 55.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 18 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saratov State Medical University" #1 sponsor was "Materia Medica Holding" with 6 trials, followed by "Celgene" with 5 trials sponsored, "H. Lundbeck A/S" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Valenta Pharm JSC" with 4 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saratov State Medical University" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Atlant Clinical Ltd." with 1 trials as a collaborator, "Chemical Diversity Research Institute" with 1 trials as a collaborator and "Dr. Falk Pharma GmbH" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Saratov State Medical University" are "Acute Respiratory Infection" (4 trials), "Common Cold" (4 trials), "Influenza, Human" (4 trials), "Depressive Disorder, Major" (3 trials) and "Viral Infection" (3 trials). Many other conditions were trialed in "Saratov State Medical University" in a lesser frequency.

Most popular intervention types in "Saratov State Medical University" are "Drug" (54 trials), "Other" (2 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Rituximab" (4 trials), "Idelalisib" (3 trials), "Ingavirin" (3 trials) and "Pembrolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Saratov State Medical University" are 54 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saratov State Medical University". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Saratov State Medical University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saratov State Medical University, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".